Newsroom

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Esperion Therapeutics, Inc. (NasdaqGM: ESPR) to funds managed by ARCHIMED. Under the terms of the proposed transaction, shareholders of Esperion will receive $3.16 per share in cash and the right to participate in contingent milestone payments for each share of Esperion that they own. KSF is se...

PARIS--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Paris:ALMKT) : Place de cotation : Euronext Growth Paris Code ISIN : FR0010609263, Mnémonique : ALMKT Site web : www.maunakeatech.com Date Nombre de titres composant le capital en circulation Nombre total de droits de vote Total Brut (1) Total net (2) 24 avril 2026 194 388 303 195 471 340 195 471 340 (1) Le nombre de droits de vote bruts (ou droits de vote « théoriques ») sert de base de calcul pour les franchissements de seuil. C...

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: Median Technologies (Paris:ALMDT) : Nombre d'actions composant le capital 38 202 387 Nombre réel de droits de vote* (déduction faite des actions auto-détenues**) 38 140 982 Nombre théorique des droits de vote* (y compris actions auto-détenues**) 38 179 187 (*) Les actions de préférence de catégorie E sont sans droits de vote (**) En application de l’article 223-11 du Règlement Général de l’Autorité des Marchés Financiers A propos de Me...

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFC 529900JEHFM47DYY3S57 27/04/2026 FR0014000MR3 35 000 62.5188 XPAR EUROFINS SCIENTIFC 529900JEHFM47DYY3S57 27/04/2026 FR0014000MR3 5 000 62.3938 CEUX EUROFINS SCIENTIFC 529900JEHFM47DY...

CHICAGO--(BUSINESS WIRE)--In support of small-business owners challenged by rising operational costs, ComEd is celebrating an important milestone: More than 100,000 small businesses across northern Illinois have participated in free facility assessments that identify opportunities to save both money and energy. In recognition of National Small Business Week, May 3-9, ComEd joined small-business owners and local elected officials to call attention to the small-business offering available through...

CHICAGO--(BUSINESS WIRE)--Con el fin de apoyar a los dueños de pequeños negocios que se enfrentan al aumento de los costos operativos, ComEd celebra un logro importante: más de 100,000 pequeños negocios del norte de Illinois han participado en evaluaciones gratuitas de sus instalaciones que les permiten ahorrar dinero y energía. Con motivo de la Semana Nacional de los Pequeños Negocios, que se celebra del 3 al 9 de mayo, ComEd se unió a propietarios de pequeños negocios y oficiales electos loca...

PARIS--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Paris:ALMKT): Listing: Euronext Growth Paris ISIN code: FR0010609263, Ticker: ALMKT Website: www.maunakeatech.com Date Number of shares comprising the capital in circulation Total number of voting rights Gross Total (1) Net Total (2) April 24, 2026 194,388,303 195,471,340 195,471,340 (1) The gross number of voting rights (or "theoretical" voting rights) serves as the basis for calculating the thresholds. In accordance with Article...

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALFNL), société biopharmaceutique développant des médicaments botaniques innovants pour le traitement des addictions, annonce que ses travaux sur NFL-102, candidat médicament en sevrage tabagique, ont été sélectionnés pour deux présentations de poster lors d’événements scientifiques internationaux majeurs en juin 2026. 1) College on Problems of Drug Dependence (CPDD) du 13 au 17 juin 2...

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALFNL), a biopharmaceutical company developing innovative botanical drugs for the treatment of addictions, announces that its work on NFL-102, its drug candidate for smoking cessation, has been selected for two poster presentations at major international scientific events in June 2026. 1) College on Problems of Drug Dependence (CPDD), June 13–17, 2026 The Company will present a poster...

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares 38,202,387 Number of real voting rights* (excluding treasury shares**) 38,140,982 Theoretical number of voting rights* (including treasury shares**) 38,179,187 (*) Class E preference shares are non-voting (**) pursuant to article 223-11 of the AMF’s General Regulations About Median Technologies: Pioneering innovative software as a medical device and imaging services, Median Tech...